Phil Skolnick is Chief Scientific Officer of OPIANT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of OPNT, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 23,548 shares (Common Stock) at a price of $20.0 per share, resulting in proceeds of $470,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Phil Skolnick Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2023
SELL
Sale (or disposition) back to the issuer
$470,960 $20.0 p/Share
23,548 Reduced 100.0%
0 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
2,000 Added 50.0%
2,000 Common Stock
Jan 27 2023
SELL
Open market or private sale
$9,724 $20.26 p/Share
480 Reduced 2.18%
21,548 Common Stock
Jan 09 2023
SELL
Open market or private sale
$7,453 $20.2 p/Share
369 Reduced 1.65%
22,028 Common Stock
Jan 05 2023
SELL
Open market or private sale
$28,704 $20.2 p/Share
1,421 Reduced 5.97%
22,397 Common Stock
Jul 14 2022
SELL
Open market or private sale
$7,430 $11.85 p/Share
627 Reduced 2.56%
23,818 Common Stock
Jun 27 2022
BUY
Grant, award, or other acquisition
-
2,000 Added 7.56%
24,445 Common Stock
Jan 27 2022
SELL
Open market or private sale
$39,756 $26.19 p/Share
1,518 Reduced 6.33%
22,445 Common Stock
Jan 10 2022
SELL
Open market or private sale
$11,739 $30.49 p/Share
385 Reduced 1.58%
23,963 Common Stock
Jan 04 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 33.01%
24,348 Common Stock
Jan 26 2021
BUY
Grant, award, or other acquisition
-
8,198 Added 39.9%
12,348 Common Stock
PS

Phil Skolnick

Chief Scientific Officer
Santa Monica, CA

Track Institutional and Insider Activities on OPNT

Follow OPIANT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPNT shares.

Notify only if

Insider Trading

Get notified when an Opiant Pharmaceuticals, Inc. insider buys or sells OPNT shares.

Notify only if

News

Receive news related to OPIANT PHARMACEUTICALS, INC.

Track Activities on OPNT